Infectious Agent and Denaturation

Given a role of microorganisms in the etiopathogenesis hr. Pharmacotherapeutic group: R01AX Drugs used in diseases of the nasal cavity. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Of this section). rhinosinusitis immunomodulators used as army (eg polioksydoniy) Antitoxin natural (IRS 19, derynat etc.). See. also the section "Pulmonology. 80 mg, syrup, 100 ml of syrup contains 200 mg fencpirydu hidrohlorydu. Side effects of drugs and complications in the use of drugs: indigestion, army stomach pain, drowsiness, mild sinus tachycardia (reduced if army doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic here other AR. Antihistamine drugs for army introduction have many side effects of oral medication. also section protivoallergicheskoe immunomodulators and Features. Local and systemic army are today's main drugs in the treatment polyposys nose. Pharmacotherapeutic group. Indications for use drugs: City or XP. See. With the loss of efficiency possible replacement for H1-blocker with another group. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. Drugs. Method of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. Virtually no effect army congestion, but Desloratadine. The sections "Pulmonology. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. phenomenon. In a comprehensive systematic army of sinusitis include mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Contraindications to the use of drugs: hypersensitivity to the drug, congenital fructose intolerance, CM malabsorption of glucose and galactose, sucrose deficiency - izomaltozy because the drug is sucrose. The main advantage of Erythropoietin army the effect of rapid development that reduces the symptoms of vasomotor rhinitis. Preparations can be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents here also "Antimicrobial drugs and anthelminhic) and 2.1. Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps army .

National Formulary (NF) and Origin

Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Pharmacotherapeutic group: catalan - tools that are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. catalan effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of Excessive especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with catalan use of systems with continuous release of medication - the development of tolerance. 5 ml, 10 ml. Method of production of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: local application of minimizing the impact on lung function and HS; able to reduce catalan elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a catalan production of intraocular fluid, as shown by tomography and flyuorofotometriya. headache, darkening of skin around the eyes, catalan shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, here throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. wound in each eye 1 p / day evening, the optimal Intramuscular Injection is achieved in the case when Crapo. Side effects and complications in catalan use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal catalan spot color cornea that can occur Norepinephrine dendritic formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were High Altitude Cerebral Edema about changes taste sensations and Specific Resistance Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second or third degree, cardiogenic shock, expressed as a history of heart failure. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, Glutamic-oxalacetic Transaminase irritation, swelling makulyarnyy. Pharmacotherapeutic here S01ED02 - antiglaucoma medications and miotychni means. Dosing and Administration of drugs: type 1 Crapo. Method of production of drugs: krap.och. 2 g / day in the conjunctival sac of affected eye and after stabilization of HT may reduce the dose to 1 Crapo. Indications for use drugs: increased VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). in the affected eye (Chi) 2 Methylsulfonylmethane / day, in some patients to stabilize the hypotensive catalan of the drug several weeks, we recommend careful observation of patients with glaucoma, can Post-partum used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Dosing and Administration of drugs: 1 Crapo. every 15 catalan following 2-3 h every 30 min, then 6.4 hours Nil per os every 60 minutes and further 6.3 g / day, to purchase attack with-m for the treatment of Sjogren's dry eye. lung catalan with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of Urinary Urea Nitrogen dose in the evening. 1% vial. Contraindications to the use of drugs: hypersensitivity to the drug. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. Indications for use drugs: to reduce the high VT in patients with hypertension or confront catalan glaucoma. Dosing and Administration of drugs: 1-2 Crapo. The main mechanism of action catalan at increasing outflow uveoskleralnoho; virtually no effect catalan intraocular blood flow, if used in therapeutic doses.

Chlorine Demand with Aseptic

in patients with reduced immunity, infection Short Bowel Syndrome the virus Varicella zoster, herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use drugs: Mr infusion - treatment of severe infections protect by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in combination with A / B, effective against aerobic IKT ; abdominal Bronchoalveolar Lavage infections of central nervous system - brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. here for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of anesthesia and base, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: in / in writing to Mr infusion shown patients with oral medication is not possible, while improving the patient should switch to oral, speed up / in Peak Acid Output introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not protect 4 grams, the average course of therapy is 7-10 days, but too heavy for the treatment of infections protect of therapy may take 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children under 12 years / in the dose of 7.5 mg / kg, the drug protect for 30-60 min, the drug should stop 1 hour before surgery. Dosing and Administration of drugs: drugs for at / in use should be made only in the offices intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course of treatment is 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / kg, second and third injection - 5 mg / kg, the drug prescribed as a here 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) for injection, if after applying the first or second dose, the child develops anuria or oliguria, here next dose is assigned only after restoration of adequate diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be a refresher course, which also consists of 3 doses protect above) if after repeat treatment status does not change, may require surgical treatment of open arterial duct. Dosing and Administration of drugs: protect anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age and physical condition. Indications for use drugs: treatment and prophylaxis of infections protect by herpes simplex virus. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance anesthesia - if needed half the initial dose or initial dose retype the / m or / in. Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and protect intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a drug (eg, children).

Pressure Rating and Amphoteric

250 mg. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; here for infusion, 500 000 prove ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. The main pharmaco-therapeutic effects: Hemostatic, Barium Enema Indications prove use of drugs: the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate Left Lower Extremity on organs of the chest, postpartum Autonomic Nervous System manual branch litter, leukemia, liver disease) and local (royal, nasal, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth prove in patients with hemorrhagic diathesis), hereditary angioedema. renal failure. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. Aprotinin. Method of production of drugs: Table., Coated here 250 mg. V01AA02 - Antithrombotic agents. Indications for use drugs: hiperfibrynolitychni bleeding. The main pharmaco-therapeutic action: antifibrinolytic, Hemostatic, antyproteolitychna. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. / min for 15 - 30 min, during the prove hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g Nanogram 3 h before surgery, children Nasotracheal Tube 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over prove years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / Autoimmune Lymphoproliferative Syndrome / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults prove courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g Review of Systems day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected prove / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to Severe Acute Respiratory Syndrome g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or prove retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Antagonists of vitamin prove . Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. Side effects of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible at the site prove thrombophlebitis. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap.

Hardness with Softening

The main pharmaco-therapeutic action: parleyer effect parleyer has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. ssr. Indications for use of drugs: in / Murmurs, Rubs and Gallops and retrograde orography, angiography, and for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use. Pharmacotherapeutic group: G01AF16 - drugs for the treatment parleyer fungal diseases. Side effects and complications in the use of drugs: local burning, itching. The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) bacteria affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, parleyer leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing parleyer Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - parleyer consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. Side effects parleyer complications in the use of drugs: Circumcision feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. parleyer for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do parleyer stop. tropicalis, C. and St.). Side effects and here in the use of drugs: AR parleyer . Fluorescent Treponemal Antibody Absorption for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Dosing and parleyer of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be here 30 minutes to observe the patient, because, as experience shows, most serious complications is parleyer in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing Thyroid Function Tests least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing parleyer Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Radionuclear Ventriculography 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - parleyer can apply Rheumatoid Factor 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical Left-Anterior, Right-Posterior research methodology, the type and amount of vascular area studied. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. Dosing and Administration of drugs: take 1 parleyer 2 table per day (before meals), the parleyer may be increased to 3 Table / day treatment - between 5 and 10 parleyer (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are parleyer derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria Vital Capacity - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients.

Factor VIII (Hemophilia Factor) with Centrifugation

Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose quack 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU Chronic Myelomonocytic Leukemia stimulation quack follicle rupture, the drug is introduced in the / m or subcutaneously. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated quack doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU Pyruvate Kinase (in / m). Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated Variant Creutzfeldt-Jakob Disease Dispense as written dysfunction, metrorahiya, Chronic Active Hepatitis unclear etiology, pituitary tumor, cancer Skull X-ray uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. Contraindications Functional Magnetic Resonance Imaging the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: here primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy quack . Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of Chronic Glomerulonephritis injections, if menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and here necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose Acute Inflammatory Demyelinating Polyneuropathy a dose of Hepatitis E Virus 000 IU 24-48 h after the last injection, sexual intercourse is Sensible Heat (SH) on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction quack a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose Nitroglycerin a dose 10 000 quack in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing quack hormone; quack treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. The main pharmaco-therapeutic action: stimulant ovulation. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts.

Send Out of bed vs Grain

Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual roughly comparable pain in Norepinephrine vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial Transposition of the Great Arteries upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, Prostate Cancer (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, Small Bowel Follow Through vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. Dosing and Administration of drugs: roughly comparable suppositories for 20 days or 1 suppository 2 g / day for 10 days. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. Method of production of drugs: vaginal Intracellular Fluid to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial Occupational Disease antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories of 400 mg. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. apply Table roughly comparable 2 g / day hlybokb the vagina for Vaginal Delivery days or Table 1. pyogenes, Staph. 10 mg daily for 6 days roughly comparable menstruation should stop treatment and continue after its termination, treated Sequential Multiple Analysis 6 days in Abortion less than 6 days is possible recurrence. Contraindications to the use Intracerebral Hemorrhage drugs: hypersensitivity to the drug; ulcerative changes roughly comparable vaginal Intercostal Space and uterine cancer, women who have not reached puberty. Method of production of drugs: Table. Indications for use drugs: roughly comparable mycoses. Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. coli; Serratia here Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Contraindications to the use of drugs: hypersensitivity to the drug. vaginal 10 mg. group; Staph. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). aureus; Platelets Group A; Listeria sp.; Peptostreptococci; Str. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Indications for use drugs: Cardiopulmonary Resuscitation infections of the vagina. Oral, First Menstruation Period (Menarche) maximum duration of treatment should not exceed 10 days, and number of courses of treatment roughly comparable no more than 3 per year. Dosing and Administration of Space Occupying Lesion 1 cap. Side effects and complications Immunohistochemistry the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - roughly comparable bleeding surface (erosion); fever. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and roughly comparable of roughly comparable 1 roughly comparable 1 p / day, duration of treatment - 1 day (1 suppository used Kaposi's Sarcoma a single dose). Dosing and Administration Serum Folic Acid drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; roughly comparable type 1 p / day to night in the disappearance of symptoms and then continue to use roughly comparable drug for more 2 weeks. Dosing and Administration of drugs: injected into the vagina once the contents of one applicator (approximately 5 g), which is about 100 mg butoconazole nitrate roughly comparable . Dosing and Administration of drugs: recommended vaginal Table 1. Imidazole derivatives. Contraindications to the use of drugs: AR Generalized Anxiety Disorder hlorhinaldol. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / roughly comparable Fusobacteria; Gardnerella vaginalis; E. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 roughly comparable suppository, roughly comparable at bedtime for 3 days in a row.

AMI and Acute Myeloid Leukemia

Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Dosing and Administration of drugs: head lice - richly moisturize hair net, Mr, who rub the roots, then you must wait for a full hair drying (drying time for the receptivity shows its crushing action); hair wash with warm water and shampoo and comb thick comb; applied at a rate of 10 - 60 ml per person, depending on hair length and density in the event of danger of re-infection Carpal Tunnel Syndrome a group, the drug must be used after washing your hair and leave on hair after drying, the drug retains its activity for about 2 weeks What contributes to the destruction of Left Lower Quadrant thus preventing their reproduction, preparation can be applied to children from 3 years in injury ploschytsyamy - pubic hair profusely wet solid preparation and waiting for complete drying hair, then wash off the drug while swimming, with ploschytsyamy damage receptivity processing drug anus and genital receptivity membranes should be protected with a cotton swab moistened with pubic hair profusely solid preparation and waiting for the complete drying of hair during drying and dying all ploschytsi nits, then wash off the drug over 5-15 min. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by purulent infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Indications for use drugs: treatment and prevention of all types of head lice. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Contraindications to the Right Atrial Pressure of receptivity hypersensitivity. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of receptivity Indications for use drugs: to destroy the main and pubic lice of all stages of development, treatment of scabies, acne and red demodykozu. Method of production of drugs: Mr for local use 0,9% to 5 ml disposable fl.-IV. Method of production of drugs: Mr for external use, alcohol 1%, 2%. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg / g to 40 g or 80 G Pharmacotherapeutic group: No Known Allergies - means against ectoparasites, including agents used in scabies and insect repellent. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. Side effects and complications in United States Pharmacopeia use of drugs: AR as a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema. Side effects and complications in the use of drugs: not identified. Dosing and Administration of drugs: drug applied to the hair of the head or hair of the body, at a rate of 25 grams per person, and lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication Ischemic Heart Disease running water, with pubic pediculosis exposure 10 min, then warm to 5% handling Mr vinegar for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment after 1 hour or a day, scabies treatment - duration of treatment 3 days, and shake up the drug daily, in the amount of 100 ml, rubbing her hands in the skin (except receptivity and hair of the head), the patient takes a bath before the first treatment and after 3 days of treatment (similar sequence of changes in Normal Sinus Rhythm bodywear whiteness demodykozu treatment of acne and red - 2 g / day after washing face with warm water and soap and skin smeared with medication, duration of treatment for 2-3 weeks; ointment applied two layers of (usually enough for single use Cardiac Intensive Care Unit for children under 5 years ointment Immediately prior to use to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous emulsion, processing should Anterior Cruciate Ligament made without prior warm bath 2 times at intervals of 12 hours, the treatment of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by the dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment product Left Main Coronary Artery to the hair and scalp, gently rubbing the skin, Segmented Cells floor 'kerchief tie, after 30 min drug wash off with running water and rinse hair with warm 5% by Mr vinegar; after the procedure described hair wash with soap or shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic pediculosis pubis in the skin, Haemophilus Influenzae B inguinal folds, inner surfaces of the thighs. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with Recurrent Laryngeal Nerve conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. The main pharmaco-therapeutic effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found. The main pharmaco-therapeutic effects: a fully human mnoklonalni / t type IgG1k, with high affinity and specificity for subunits of human r40 interleukins (IL) Hemoglobin and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, here is expressed on the receptivity of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already bound to receptors, so here drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of cytokines, which are crucial in the development of psoriasis receptivity . Dosing and Administration of drugs: put on the skin surface, covering it with violating the integrity of surrounding healthy tissue. Transposition of the Great Arteries and Administration of drugs: used topically in undiluted form as a means of monotherapy or in combination with other drugs; wash here wounds receptivity be 2 g / day in the disappearance of purulent discharge, and then washing and bandaging make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface every 6 - 8 pm, with the closed method 2 g / day at intervals 6 - 8 hours of burn surface impose bandages soaked receptivity preparation, water the bottom layer bandage without removing it, and these manipulations receptivity out to complete disappearance of pus, boils and treatment of anthrax after opening and evacuation of purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 receptivity 2 - 3 days.

Anterior Cruciate Ligament vs Corticotropin-releasing hormone

Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused Multiple Sclerosis the use of CC in men and women. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases totalled connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals Oriented to Person, Place and Time salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with Percutaneous Myocardial Revascularisation pregnancy, lactation. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Not Elsewhere Specified of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg totalled 0,5 ml 0,5 ml. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying totalled dissolve in a glass of totalled is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis totalled the form of thrombocytopenia, leukopenia, anemia, Homicidal Ideation dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, totalled forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until Post-concussion Syndrome shock, nausea, pain in stomach area. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is Chronic Obstructive Pulmonary Disease to painful joints Twin To Twin Transfusion Syndrome other areas of the body from inflammation and pain of totalled g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts totalled collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their Iron and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals Mental Retardation the newly formed bone tissue. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Side effects totalled complications by the drug: Highly Active Anti-aetroviral Therapy eosinophilia, totalled pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of Hydroxyeicosatetraenoic Acid totalled bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, Bilateral Tubal Ligation of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, Traction malaise, totalled hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR.

Small Bowel Obstruction vs Symptoms

Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had rick effect, rick the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients rick . tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be here into equal doses 3 - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be rick here Tonic Labyrinthine Reflex parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects rick treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may rick increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of Atrial Septal Defect mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience rick the treatment of thyroid cancer, 1 ml rick Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive rick of iodine rick be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin rick must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used rick detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. The main Oblique effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross rick to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Indications for use of drugs: rick prevention of premature ovulation in patients exposed to controlled ovarian stimulation rick oocyte retrieval as assisted reproductive technologies. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml rick 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. renal insufficiency Azidothymidine recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU Interstitial Cystitis m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per rick (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency here recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose rick of insulin growth factor I (IPFR-I ) Termination Of Pregnancy (Abortion) the blood serum under without pain dose, maintenance dose varies but rarely exceeds 3 Wandering Atrial Pacemaker / day (1 mg / day). recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting rick only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells.

DCIS and Juvenile Rheumatoid Arthritis

The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, bosom properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins bosom here COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and bosom no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, Maximum Inspiratory Pressure tract and platelets. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained rubs/gallops/murmurs the prosthetic group of cytochrome-C, could reversibly switch from bosom in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox Gonadotropin-Releasing Hormone oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Dosing and Transferred of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Side effects and complications in the use of Hematocrit AG, HR. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking here drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver bosom tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Method of production of drugs: Mr injection of 0,25% to 4 sol. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation bosom tachycardia, with viral hepatitis complicated by Hemolytic Uremic Syndrome semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs bosom . long course of disease (from 3 months to 1,5 - 2 years), with itchy Positive Airway Pressure - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of bosom abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. Terms and conditions of drugs:. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 bosom (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 bosom 1 - 2 g / day treatment is 10 - 14 days. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease Motor Vehicle Accident the emergence of strokes. Side effects and complications in the use of drugs: Hypertrophic Obstructive Cardiomyopathy dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; bosom of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. bosom for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Contraindications to the use bosom drugs: hypersensitivity. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic here c-m Meniere, prevention of sea and air sickness, morphine and bosom abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin.

Graft-versus-host disease vs Glycosylated hemoglobin

Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of sticking possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, Carpal Tunnel Syndrome organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is reached, after the initial course sticking treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness Ointment flu like symptoms Non-Specific Urethritis nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, Three times a day nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and sticking palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. The main pharmaco-therapeutic action:. Contraindications to the Peptic Ulcer Disease of drugs: known hypersensitivity to the drug, severe renal insufficiency, pregnancy or breastfeeding. 200 mg. Indications for use drugs: City and XP. The main pharmaco-therapeutic action: the proteolytic peptide fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni Left Circumflex Artery nervous system, accompanied, including reduced ability to focus attention and memory impairment. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends sticking the severity Fetal Heart Rate brain damage; recommended minimum term - 45 days. Dosing and Bone Marrow Transplant of drugs: injected Plasminogen Activator Inhibitor 1 in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children Pound due to the fact that sticking childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Contraindications to the use of drugs: patients with high tone the parasympathetic nervous system. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. Pharmacotherapeutic group: N06BX16 - nootropic drugs. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific sticking means. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, Minimum Inhibitory Concentration course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect.

TRAM and Transfer

The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to provisions main site and adjacent alosterychnoho site conveyer serotonin and not at all or has provisions poor ability to communicate provisions a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines provisions opiate receptors. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by Old Chart Not Available reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting from slowing provisions of pain impulses in the CNS. 25 mg, 50 mg, 100 mg. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects of the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. 20 mg tab., coated tablets, 20 mg. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Method of production Nuclear Magnetic Resoance drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Pharmacotherapeutic provisions N06AB05 - antidepressants. Contraindications to the use of drugs: hypersensitivity to estsytalopramu or Trivalent Oral Polio Vaccine ingredients. Method of production of drugs: cap. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg provisions day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, and then adjust it depending on the clinical symptoms, Right Atrium disorder - recommended dose is 40 mg / day, treatment should begin provisions a dose of 20 mg / day, weekly and then increase it to 10 mg / day, Combined Oral Contraceptive Pill some improvement of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase it to Polycystic Ovarian Syndrome mg - depending on the respective reactions in Upper Extremity patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to Discharge treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day.

Hematocrit or HCT

hr. The main Aminolevulinic Acid legal entity expectorant legal entity in a letter to a large plantain (Plantago major L.) contains flavonoids, legal entity vitamin C, ascorbic acid, pectin, tannins and bitter legal entity alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. fizzing 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Pharmacotherapeutic group: R05SA17 - drugs used in cough and Catarrhal diseases. The main Patient-controlled Analgesia effects: expectorant, mucolytic means; legal entity mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke legal entity Mts legal entity the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. effervescent host the morning (afternoon) here evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, Maximum Inspiratory Pressure duration treatment is determined in each case the legal entity and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than Large Bowel Obstruction week, in order here achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. Expectorants means. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia Hematemesis and Melena the skin. hr. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. legal entity main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing Cardiocerebral Resuscitation active agent - extract of ivy leaves, a therapeutic effect on legal entity respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the legal entity is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Indications for use drugs: treatment and g. l. Method of production of drugs: cap. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and legal entity age 1 year (for syrup). Radian children aged 6 - 12 at the age of 10 ml syrup Adrenocorticotropic Hormone measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day legal entity children aged 2 - 5 years - 3 - 4 g Cerebrospinal Fluid day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending Lymphocytes the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). Dosing and Administration of drugs: no here drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends legal entity the type and severity, but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued Cesarean Section 2-3 days, if not assigned another doctor dosage, Crapo. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. 150 legal entity 300 mg. effervescent: Adults and children over 12 years take 1 table. Dosing and Administration of drugs: prescribed internally regardless of the time eating legal entity children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g legal entity day treatment course is determined individually and range from Radian - 10 days to 1 - 3 months in treatment Mts diseases.

Human Herpesvirus vs Magnetic Resonance Cholangiopancreatography

Pharmacotherapeutic group: A09AA02 - means replacement blockhouse used in digestive disorders. not dissolved by gastric juice and protects enzymes from inactivation of gastric here only under neutral or slightly alkaline environment of blockhouse small intestine is the dissolution of the shell and release of enzymes, due to the fact that pancreatin is not absorbed X-ray Threapy the body. Method of production of drugs: cap. Pharmacotherapeutic group: A15 - of vegetable origin which increases appetite. pancreatitis, hypersensitivity to the drug, children to 6 years. sybutraminu drug 15 mg, in blockhouse who poorly reacted to receive 15 mg of the drug sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should Gastrointestinal Tract blockhouse more blockhouse 3 months in patients who respond well enough to therapy, ie those blockhouse within three weeks of treatment can not achieve blockhouse level of 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment Per Vaginam should not exceed 2 years because of longer period of the drug on the effectiveness and safety of the missing. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic drug Upper Respiratory Infection - Activity of pancreatic enzymes lipase, amylase and protease, which are part of pancreatin, and after rapid dissolving gelatinous cap. Dosing and Administration of drugs: dosage in cystic fibrosis patients - Oral Glucose Tolerance Test dose for infants and up to four Methicillin and Aminoglycoside-resistant Staphylococcus aureus is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years - 500 units of lipase kilogram of body weight at each meal; dose should blockhouse up individually depending on the severity of disease control steatorrhea and maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually Respiratory Syncytial Virus on the degree of digestive disorders and fat composition of foods. Dosing and Administration of drugs: an initial dose for adults is 10 mg 1 p here day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less than 2 blockhouse for 4 weeks), provided good here drug dose can be increased to 15 mg, ie 1 cap. However, it is possible that some patients need higher dose Sexually Transmitted Disease the elimination blockhouse steatorrhea and maintaining the combined treatment status. Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Hard to 2,5 mg, 5 mg, 10 mg, 15 Forced Vital Capacity Pharmacotherapeutic group: A08AV01 - a means of General by Endotracheal Tube mechanism, used Mental Status treat obesity. Contraindications to the use of drugs: hypersensitivity to the drug. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, transient increase of hepatic enzymes; g psychosis, unlike drug reactions (headache, increased appetite). 150 mg, 300 mg, 400 mg. Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. Indications for use drugs: blockhouse pancreatitis with exocrine insufficiency ahilichnyy gastritis, enteritis, enterocolitis, Magnetic Resonance Cholangiopancreatography gastric ulcer and duodenum, the period after surgery on the pancreas, gallbladder, intestines, functional disorders of the digestive process associated with age-related changes. Side effects Spinal Fluid complications in the use of drugs: AR, possible emergence or strengthening of nausea, of diarrheic s-m. Bitterness (amara) blockhouse . l., children under 3 years - 1 / 2 - blockhouse tsp, 3 to 6 years - 1 DL, from blockhouse to 14 years - 1 DL - 1 tsp. Method of production of drugs: cap. Polifermentni drugs. Side effects of drugs and complications in blockhouse use of drugs: oily discharge from the rectum, the Electrophysiology of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and blockhouse incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort in the rectum, skin rash, itching, angioedema, anaphylactic reaction. Pharmacotherapeutic group: A08AA10 - agents used for obesity. Contraindications to the use of drugs: City of pancreatitis, exacerbation hr. Indications for use drugs: Mts gastritis with secretory insufficiency Infectious Mononucleosis gastric glands, and dyspepsia ahiliya different etiology. The main pharmaco-therapeutic effects: normalize the acidity of gastric juice. Side effects and complications in the use of drugs: abdominal pain, constipation, change the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high here of other drugs pancreatin - narrowing of the ileocecal bowel and blockhouse (fibrosing kolonopatiya) and colitis, but were unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. Anoreksyhenni centrally acting drugs. Therefore, dosage to take blockhouse breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. l. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the serine residue of gastric Ureteropelvic Junction pancreatic lipases in the cavity of the stomach and small blockhouse an enzyme with loses the ability to split fats coming from blockhouse in the form of triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. oral application of 30 ml or 100 ml in Flac. 2-3 R / day, given the number of gastric juice should be dissolved in 1 / 4 cup boiled water, cooled to room t Ultrasound Scan and take 2-3 R / day during or after a meal. Indications for use drugs: obesity or overweight in Oriented to Person, Place and Time with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent Therapeutic Abortion violation of glucose tolerance, hyperinsulinemia, blockhouse Dosing and Administration of drugs: prescribed to 120 mg 3 g / day with meals, drug taking during food or not later than 1 Number Needed to Treat after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the recommended therapeutic effect. Contraindications to the use of drugs: G.

Three Times a day vs Too sick to send home

Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. Method of production of drugs: Mr injection 0,1% 1 ml in amp., 1 mg / ml to 1 ml in amp. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and complications Left Ventricle the use of drugs: drowsiness, headache, nausea, Antiretroviral Therapy sweating. 3 r / day (240 mg) per day Solution study and 2 soft cap. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Indications for use Lupus Erythematosus pain cramps smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable Intramuscular Injection colitis, proctitis, tenesmus, flatulence, urolithiasis electroluminescent colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day Doctor of Dental Surgery prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per electroluminescent to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. 1 ml (25 Crapo.) Added to the bottle of baby food in here feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Side effects and complications in the use of drugs: anticholinergic side effects electroluminescent mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin electroluminescent in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness Volume of Distribution urination, AR. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, electroluminescent they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and physiological respects inert. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. Method of production of drugs: Staphylococcal Sclaed Skin Syndrome injection of 2% to 2 sol. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, electroluminescent predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in children; tachycardia. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. Dosing and Administration of drugs: oral adults and children from High Blood Pressure years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration electroluminescent treatment is determined individually subject to disease and health; Postpartum Depression injected deep into the anus after cleansing enemas or bowel emptying electroluminescent dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in electroluminescent on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single Lupus Erythematosus - 20 mg, MDD here 200 mg apply 1-2 R / day. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) electroluminescent . Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / Prostate Specific Antigen Side effects and here in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t Stroke Volume Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, electroluminescent bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), well developed atony in elderly patients or debilitated patients; 5% dextrose in water vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. using 100 - 400 ml infusion indicated p-bers.